Acetazolamide‑Induced Hypocapnia: Mechanisms, Therapeutic Use, and Safety Guidelines

Mechanism of Action

Acetazolamide directly stimulates respiration in addition to producing metabolic acidosis, thereby lowering arterial CO₂ through a central chemoreceptor‑driven increase in ventilation. American Academy of Sleep Medicine (2025) describes this respiratory‑stimulant effect as distinct from simple metabolic compensation. 1

Despite its hypocapnic effect, acetazolamide is recommended for the treatment of central sleep apnea because it stabilises the ventilatory control system and raises the apneic threshold. American Academy of Sleep Medicine (2025) includes this indication in its CSA management algorithm. 2

The guideline advises mandatory monitoring of serum electrolytes (especially potassium) after 2–4 weeks of therapy, because acetazolamide‑induced metabolic acidosis can precipitate arrhythmias. American Academy of Sleep Medicine (2025) classifies this as a Class I recommendation. [1][2]
Hypokalemia is a recognized adverse effect of acetazolamide; when combined with the drug‑induced acid‑base shift, it further increases the risk of cardiac arrhythmias. American Academy of Sleep Medicine (2025) highlights this risk in its safety statements. [1][2]

In patients with conditions that already promote hyperventilation (e.g., CSA secondary to heart failure or exposure to high altitude), acetazolamide’s respiratory‑stimulant properties may exacerbate acid‑base disturbances. The guideline cautions clinicians to weigh this risk before prescribing. American Academy of Sleep Medicine (2025). [1][2]3

Concomitant use of acetazolamide with additional diuretics at altitude markedly increases the likelihood of dehydration and electrolyte imbalance, heightening the danger of severe hypokalemia and related complications. This observation is reported in the European Heart Journal (2018). 4

Maintain the mild hypocapnia that results from acetazolamide therapy in patients with compensated metabolic acidosis; abrupt restoration of normocapnia (e.g., during sedation or ventilator adjustments) may precipitate cerebral herniation in those with elevated intracranial pressure. (Guideline caution, American Academy of Sleep Medicine, 2025). [1][2]
Avoid combining acetazolamide with other diuretics in patients traveling to or residing at high altitude to prevent excessive fluid loss and electrolyte disturbances. (Evidence from European Heart Journal, 2018). 4